Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. od Gershlick, A, Stephens-Lloyd, A, Hughes, S, Abrams, K, Stevens, SE, Uren, N, de Belder, A, Davis, J, Pitt, M, Banning, A, Baumbach, A, Shiu, M, Schofield, P, Dawkins, K, Henderson, R, Oldroyd, K, Wilcox, R

A randomised, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following... od Adlam, D, Uren, N, Oldroyd, K, Munir, S, Sharp, A, Zaman, A, Contractor, H, Kiss, R, Edes, I, Jr, ZM, Garcia, MJ, Musialek, P, Tomcsanyi, J, Ptaszynski, P, Nagy, G, Szachniewicz, J, Siegel, L, Shirodaria, C, Selvanayagam, JB, Tulloch, S, Campfire Investigators, Channon, KM

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study od Banning, AP, Serruys, P, De Maria, GL, Ryan, N, Walsh, S, Gonzalo, N, Jan van Geuns, R, Onuma, Y, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, SP, Piek, JJ, Appleby, C, Fath-Ordoubadi, F, Zaman, A, Van Mieghem, NM, Uren, N, Zueco, J, Buszman, P, Iniguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, de Vries, T, Taggart, D, Farooq, V, Spitzer, E, Tijssen, J, Escaned, J

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. od Escaned, J, Collet, C, Ryan, N, De Maria, G, Walsh, S, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, S, Ej West, N, Piek, J, Zaman, A, Fath-Ordoubadi, F, Stables, R, Appleby, C, van Mieghem, N, van Geuns, R, Uren, N, Zueco, J, Buszman, P, Iñiguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, Hanratty, C, Cavalcante, R, Kappetein, A, Taggart, D, van Es, G, Morel, M, de Vries, T, Onuma, Y, Farooq, V, Serruys, P, Banning, A